Apnimed’s Second Core Sleep Apnea Drug Candidate, AD504, Lowers AHI
Apnimed shared data from a proof-of-concept study exploring two potential oral therapeutic candidates for the treatment of patients with obstructive sleep apnea.
Tag: Apnimed
All
Latest
Apnimed’s Second Core Sleep Apnea Drug Candidate, AD504, Lowers AHI
Apnimed shared data from a proof-of-concept study exploring two potential oral therapeutic candidates for the treatment of patients with obstructive sleep apnea.
Read More